RUSH’s Use of 3-D Printed Models and Hybrid Cold Plasma in Orthopedic Oncology with Steven Gitelis, MD

The RUSH Cancer Center has a deep commitment to accelerating innovations that bring cutting edge research to the bedside. Two examples of those innovations that Steven Gitelis, MD, and RUSH have an active role in developing are 3-D printed models, which can help to preserve healthy tissue when treating benign and malignant bone and soft tissue tumors, and hybrid cold plasma, which can help stop the recurrence of cancer after surgery.

Steven Gitelis, MD, is a highly regarded expert in the area of orthopedic oncology and limb reconstruction and currently serves as the Director of Musculoskeletal Oncology at the RUSH Cancer Center and the Director of the RUSH Center for Limb Preservation. He has been repeatedly voted as one of Chicago’s best doctors by Chicago Magazine and one of America’s top doctors by Castle Connolly. 

“Any patient who has bone cancer where you’re trying to do limb salvage and preserve as much healthy tissue as possible, they are all good candidates for 3-D printed technology. The laboratory efficacy is well established in modeling, but we’re all anxious to see the clinical outcomes and prove that these patients have better function, which is my hope and expectation.”

CME credit link:
https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/485026